Introducing GlucemaTM
The first and only point-of-care saliva test for diabetes monitoring
Salient features of Glucema test
Easy to use non-invasive test
2-5 minutes to read from a drop of saliva
Test once every 7-14 days
Provides quick estimate of recent average glucose levels to monitor treatment
Advantages Over Current Tests
Short-term index provides more rapid indication of therapy efficacy than 3 to 4-month period reflected by HbA1c
Unlike other short-term parameters such as fructosamine or 1,5-AG, the non-invasive, saliva-based Glucema POC test does not require a blood sample or a clinical laboratory